PharmacyCodes



Mykrox en es it fr

Mykrox Brand names, Mykrox Analogs

Mykrox Brand Names Mixture

  • No information avaliable

Mykrox Chemical_Formula

C18H14Cl4N2O

Mykrox RX_link

http://www.rxlist.com/cgi/generic2/micon.htm

Mykrox fda sheet

Mykrox FDA

Mykrox msds (material safety sheet)

Mykrox MSDS

Mykrox Synthesis Reference

No information avaliable

Mykrox Molecular Weight

416.127 g/mol

Mykrox Melting Point

159 - 163 oC

Mykrox H2O Solubility

1g/100mL (20°C)

Mykrox State

Solid

Mykrox LogP

6.02

Mykrox Dosage Forms

Topical cream (2%); Vaginal cream (2%); Vaginal suppositories (100mg, 200mg)

Mykrox Indication

For topical application in the treatment of tinea pedis (athlete’s foot), tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis (moniliasis), and in the treatment of tinea versicolor.

Mykrox Pharmacology

Miconazole is an anti-fungal medication related to fluconazole (Diflucan), ketoconazole (Nizoral), itraconazole (Sporanox), and clotrimazole (Lotrimin, Mycelex). It is used either on the skin or in the vagina for fungal infections. Miconazole was approved by the FDA in 1974. Miconazole prevents fungal organisms from producing vital substances required for growth and function. This medication is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Mykrox Absorption

No information avaliable

Mykrox side effects and Toxicity

Oral, mouse: LD50 = 3800 mg/kg; Oral, rat: LD50 = 3 gm/kg. Ingestion of the amounts of the components contained in a tube of cream are unlikely to produce overdosage and toxic effects.

Mykrox Patient Information

No information avaliable

Mykrox Organisms Affected

Fungi, yeast and protozoans